Melanotan I (afamelanotide, Scenesse)
Melanotan I is the research name for afamelanotide. The FDA approved it in 2019 as Scenesse, a small implant placed under the skin by a trained clinician, for adults with a rare inherited disorder that makes sunlight painful. It is not approved for tanning.
- Legal lane: FDA-approved for one rare condition, prescription only
- Evidence grade: A for its approved use
- Form: 16 mg dissolving implant inserted every 2 months
- Brand: Scenesse
What it is
Afamelanotide is a synthetic copy of alpha-melanocyte-stimulating hormone, the signal that tells skin to make melanin. It is a different molecule from Melanotan II, which acts on more receptors and also affects libido and appetite.
What the evidence shows
The approval rested on three placebo-controlled trials in 244 adults with erythropoietic protoporphyria (EPP), a condition where light exposure causes severe pain. People with the implant could spend more time in direct sunlight without pain than people with a dummy implant.
No trial has tested afamelanotide for cosmetic tanning in people without EPP.
Dosing on the label
One 16 mg implant is inserted under the skin above the hip bone every 2 months by a healthcare professional trained in the procedure. Patients are watched for 30 minutes afterward.
No dose is established for injected Melanotan I. The powder vials sold online are not the approved product. The implant releases the drug slowly over weeks; an injection of loose powder does not, and nobody has studied what it does.
Side effects and warnings
- Implant-site reactions were the most common, followed by nausea, throat pain, cough, fatigue, dizziness and sleepiness.
- It darkens skin and existing moles. The label recommends a full-body skin check twice a year to monitor moles.
Common questions
Is Melanotan I approved for tanning?
No. As Scenesse, it is FDA-approved only for adults with erythropoietic protoporphyria, a rare disorder that makes sunlight painful.
Is Melanotan I the same as Melanotan II?
No. They are different molecules. Melanotan II acts on more receptors and also affects libido and appetite.
How is Scenesse given?
One 16 mg implant is inserted under the skin every 2 months by a trained healthcare professional. No dose is established for injected Melanotan I powder.
Added in the latest update. These answers summarize the sections above; sources are listed below.
Ask an AI about this page
Opens the assistant with a question about this page already typed in. You can edit it before sending.
Ask ChatGPTAsk ClaudeAsk Perplexity
These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.